News and Announcements
Peer Estate Fully Funds 9 New Loans in Under 12 Months with Returns of up to 17%
- Published August 04, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Peer Estate is a peer-to-peer (P2P) platform for real estate debt.
Peer Estate has fully funded 9 new loans in under 12 months since launching in late 2016. We have provided our wholesale investors with returns ranging from 7% to 17% from investments as low as $5,000. Over 300 investors have signed up in this time and overwhelming demand saw our most recent $2.5m loan fully funded in just two hours on the day of release.
As a new peer to peer platform, the next 12 months will see further technology development and new staff hires as the business grows.
ABOUT PEER ESTATE
Peer Estate is a peer-to-peer (P2P) platform for real estate debt. We allow real estate borrowers and investors to engage with each other in a transparent process.
For investors, we offer competitive, stable returns, starting with as little as $5,000. For borrowers, we provide fast and efficient funding for real estate projects.
We have done this successfully for many years in the “old” world, and are now harnessing technology to bring the model to a larger audience. The founders of Peer Estate are highly experienced in this sector, and the company was seed funded by established real estate investment management firm, Qualitas.
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
